228 results
Page 2 of 12
8-K
51otov8pg b60tjm
26 Oct 23
VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program
8:00am
8-K
j33zs12 vye5aci41ep
27 Sep 23
Regulation FD Disclosure
7:30am
8-K
q7wooy
7 Sep 23
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBM
8:00am
8-K
sto1qlfhnmte v4g2wk
6 Sep 23
Regulation FD Disclosure
9:12am
8-K
EX-99.1
e2aoa hxwucwgcptn
24 Jul 23
VBI Vaccines Announces Closing of Underwriters’ Partial Exercise of Option to Purchase Additional Common Shares
8:00am
424B5
9bfo5gi ef8rmq1cilj
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
z7r11cp5l0tjg4w9ih
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
gftldniu
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-99.2
lhgxl16ltkghl 9r3r
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
sw62f45x7276rd9ye
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
jjq05
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
bc4e5
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
6xk7ps 73v8fb
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
omoq6zd0ugqhmhr sv
7 Jun 23
VBI Vaccines Announces Poster Presentation at EASL 2023
8:00am
DEFA14A
hj5w 7shmhmp1pp54dy
2 May 23
Additional proxy soliciting materials
4:05pm
DEFA14A
68y9o
1 May 23
Additional proxy soliciting materials
4:05pm